C Pedrazzani1,2, C Conti3, A Valdegamberi3, M V Davì4, S Cingarlini5, A Scarpa6, A Guglielmi3. 1. Unit of General and Hepatobiliary Surgery, University Hospital "G.B. Rossi", Piazzale "L. Scuro" 10, 37134, Verona, Italy. corrado.pedrazzani@univr.it. 2. Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, General and Hepatobiliary Surgery Unit, ENETS Center of Excellence, Verona University, Verona, Italy. corrado.pedrazzani@univr.it. 3. Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, General and Hepatobiliary Surgery Unit, ENETS Center of Excellence, Verona University, Verona, Italy. 4. Department of Medicine, Endocrinology Section, ENETS Center of Excellence, Verona University and Hospital Trust, Verona, Italy. 5. Department of Oncology, Oncology Section, ENETS Center of Excellence, Verona University and Hospital Trust, Verona, Italy. 6. ARC-Net Cancer Research Centre, Department of Diagnostics and Public Health, Pathological Anatomy Section, ENETS Center of Excellence, Verona University, Verona, Italy.
Abstract
PURPOSE: Since lymphadenectomy is crucial in midgut neuroendocrine tumor (NET) surgery, we adopted laparoscopic CME right hemicolectomy (LRH-CME) for the treatment of right colon and terminal ileum NETs. In this report, we present a series of nine cases of terminal midgut NETs (TM-NETs) treated by LRH-CME with a video demonstrating oncological principles and the surgical technique. METHODS: From September 2014 to November 2019, nine patients affected by TM-NETs underwent LRH-CME at the Unit of General and Hepatobiliary Surgery, University of Verona Hospital Trust, ENETS Center of Excellence. Clinicopathological data, post-operative and oncological outcomes were prospectively collected and analyzed. RESULTS: Tumors were in ileocecal valve or terminal ileum (5 cases), right colon (3 cases), and appendix (one case). Surgery had a curative intent (R0 resection) in 7 cases. Surgical debulking was required in 2 metastatic cases. Mean surgical time was 212 + 41 min and blood loss 47 + 24 mL. No postoperative mortality was observed. Post-operative course was uneventful in all except one case (Clavien-Dindo III). Median number of harvested lymph nodes was 21 (range, 11-31) and eight out of 9 patients were node positive (median 3, range 0-6). At a median follow-up of 18 months (range, 6-50), none of the patients suffered from mesenteric locoregional recurrence and all R0 resected patients were disease-free. CONCLUSIONS: Terminal midgut NETs represent an optimal indication for LRH-CME which increases the chance of complete resection and allows optimal lymphadenectomy. In expert hands, laparoscopic approach should be favored in consideration of good short-term outcomes.
PURPOSE: Since lymphadenectomy is crucial in midgut neuroendocrine tumor (NET) surgery, we adopted laparoscopic CME right hemicolectomy (LRH-CME) for the treatment of right colon and terminal ileum NETs. In this report, we present a series of nine cases of terminal midgut NETs (TM-NETs) treated by LRH-CME with a video demonstrating oncological principles and the surgical technique. METHODS: From September 2014 to November 2019, nine patients affected by TM-NETs underwent LRH-CME at the Unit of General and Hepatobiliary Surgery, University of Verona Hospital Trust, ENETS Center of Excellence. Clinicopathological data, post-operative and oncological outcomes were prospectively collected and analyzed. RESULTS:Tumors were in ileocecal valve or terminal ileum (5 cases), right colon (3 cases), and appendix (one case). Surgery had a curative intent (R0 resection) in 7 cases. Surgical debulking was required in 2 metastatic cases. Mean surgical time was 212 + 41 min and blood loss 47 + 24 mL. No postoperative mortality was observed. Post-operative course was uneventful in all except one case (Clavien-Dindo III). Median number of harvested lymph nodes was 21 (range, 11-31) and eight out of 9 patients were node positive (median 3, range 0-6). At a median follow-up of 18 months (range, 6-50), none of the patients suffered from mesenteric locoregional recurrence and all R0 resected patients were disease-free. CONCLUSIONS: Terminal midgut NETs represent an optimal indication for LRH-CME which increases the chance of complete resection and allows optimal lymphadenectomy. In expert hands, laparoscopic approach should be favored in consideration of good short-term outcomes.
Entities:
Keywords:
Complete mesocolic excision; Laparoscopy; Midgut neuroendocrine tumors; Right hemicolectomy
Authors: B Niederle; U-F Pape; F Costa; D Gross; F Kelestimur; U Knigge; K Öberg; M Pavel; A Perren; C Toumpanakis; J O'Connor; D O'Toole; E Krenning; N Reed; R Kianmanesh Journal: Neuroendocrinology Date: 2016-01-12 Impact factor: 4.914
Authors: Christine S Landry; Heather Y Lin; Alexandria Phan; Chusilp Charnsangavej; Eddie K Abdalla; Thomas Aloia; J Nicolas Vauthey; Matthew H G Katz; James C Yao; Jason B Fleming Journal: World J Surg Date: 2013-07 Impact factor: 3.352
Authors: J Philip Boudreaux; David S Klimstra; Manal M Hassan; Eugene A Woltering; Robert T Jensen; Stanley J Goldsmith; Charles Nutting; David L Bushnell; Martyn E Caplin; James C Yao Journal: Pancreas Date: 2010-08 Impact factor: 3.327
Authors: J Philip Boudreaux; Yi-Zarn Wang; Anne E Diebold; Daniel J Frey; Lowell Anthony; Ann Porter Uhlhorn; Pamela Ryan; Eugene A Woltering Journal: J Am Coll Surg Date: 2014-01-10 Impact factor: 6.113
Authors: Enes Kaçmaz; Heinz-Josef Klümpen; Willem A Bemelman; Els J M Nieveen van Dijkum; Anton F Engelsman; Pieter J Tanis Journal: World J Surg Date: 2021-03-30 Impact factor: 3.352
Authors: Enes Kaçmaz; Jeffrey W Chen; Pieter J Tanis; Els J M Nieveen van Dijkum; Anton F Engelsman Journal: J Neuroendocrinol Date: 2021-07-08 Impact factor: 3.627